Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Rises By 200.0%

Pharma Mar, S.A. (OTCMKTS:PHMMFGet Rating) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 1,500 shares, an increase of 200.0% from the March 31st total of 500 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 15.0 days.

Separately, Zacks Investment Research downgraded shares of Pharma Mar from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 9th.

Shares of OTCMKTS PHMMF opened at $77.00 on Thursday. The firm’s 50 day moving average price is $66.21 and its 200-day moving average price is $67.01. Pharma Mar has a 52-week low of $55.47 and a 52-week high of $124.70.

About Pharma Mar (Get Rating)

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference.

Featured Stories

Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.